Showing results (1-10 of 264) with videos related to
Sort By:
Pageof 27
The Annals of Pharmacotherapy|September 5, 2014
Vedolizumab: an α4β7 integrin inhibitor for inflammatory bowel diseasesMichael A Smith, Rima A MohammadThe Annals of Pharmacotherapy|December 18, 2014
Ledipasvir-sofosbuvir: interferon-/ribavirin-free regimen for chronic hepatitis C virus infectionMichael A Smith, Juliana Chan, Rima A MohammadAmerican Journal of Pharmaceutical Education|August 23, 2014
Use of virtual patients in an advanced therapeutics pharmacy course to promote active, patient-centered learningMichael A Smith, Rima A Mohammad, Neal BenedictExpert Opinion on Drug Safety|September 15, 2015
The changing landscape of adverse drug events associated with chronic hepatitis C virus therapyMichael A Smith, Bryan L Love, Rima A MohammadThe Annals of Pharmacotherapy|October 22, 2015
Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C InfectionMichael A Smith, Randolph E Regal, Rima A MohammadAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 24, 2010
Use of granulocyte colony-stimulating factor in patients with severe sepsis or septic shockRima A MohammadThe Annals of Pharmacotherapy|June 19, 2014
Incidence and Management of Rash in Telaprevir-Treated PatientsMichael A Smith, Heather J Johnson, Kapil B Chopra, et al.The Annals of Pharmacotherapy|May 13, 2010
Eltrombopag: a novel oral thrombopoietin receptor agonistShelby L Corman, Rima A MohammadThe Annals of Pharmacotherapy|December 7, 2006
Inhaled amphotericin B for prophylaxis against invasive Aspergillus infectionsRima A Mohammad, Kristin C KleinThe Annals of Pharmacotherapy|March 26, 2009
Clinical outcomes and pharmacists' acceptance of a community hospital's anticoagulation management service utilizing decentralized clinical staff pharmacistsAnita Airee, Alexander B Guirguis, Rima A MohammadPageof 27